La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Anti-Arrhythmia Agents (therapeutic use) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Anti-Arrhythmia Agents (classification) < Anti-Arrhythmia Agents (therapeutic use) < Anti-Bacterial Agents (administration & dosage)  Facettes :

List of bibliographic references indexed by Anti-Arrhythmia Agents (therapeutic use)

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
001099 (2012) Shubhayan Sanatani [Canada] ; James E. Potts ; John H. Reed ; J Philip Saul ; Elizabeth A. Stephenson ; Karen A. Gibbs ; Charles C. Anderson ; Andrew S. Mackie ; Pamela S. Ro ; Svjetlana Tisma-Dupanovic ; Ronald J. Kanter ; Anjan S. Batra ; Anne Fournier ; Andrew D. Blaufox ; Harinder R. Singh ; Bertrand A. Ross ; Kenny K. Wong ; Yaniv Bar-Cohen ; Brian W. Mccrindle ; Susan P. EtheridgeThe study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants.
002143 (2008) Julia Cadrin-Tourigny [Canada] ; Anne Fournier ; Gregor Andelfinger ; Paul KhairySevere left ventricular dysfunction in infants with ventricular preexcitation.
002949 (2005) D P Redfearn [Canada] ; A D Krahn ; A C Skanes ; R. Yee ; G J KleinUse of medications in Wolff-Parkinson-White syndrome.
003270 (2001) Andrew D. Krahn [Canada] ; George J. Klein [Canada] ; Raymond Yee [Canada]A Randomized, Double‐Blind, Placebo‐Controlled Evaluation of the Efficacy and Safety of Intravenously Administered Dofetilide in Patients with Wolff‐Parkinson‐White Syndrome
003925 (1998) E. Jaeggi [Canada] ; J C Fouron [Canada] ; A. Fournier [Canada] ; N. Van Doesburg [Canada] ; S P Drblik [Canada] ; F. Proulx [Canada]Ventriculo-atrial time interval measured on M mode echocardiography: a determining element in diagnosis, treatment, and prognosis of fetal supraventricular tachycardia
004120 (1994) S. Connolly [Canada]How to evaluate antiarrhythmic agents in an essentially asymptomatic population.
004C56 (1988) R. Nadeau ; A. Ackaoui ; C. Giorgi ; P. Savard ; M. Shenasa ; P. PagePQRST isoarea maps from patients with the Wolff-Parkinson-White syndrome: an index for global alterations of ventricular repolarization

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Anti-Arrhythmia Agents (therapeutic use)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Anti-Arrhythmia Agents (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Anti-Arrhythmia Agents (therapeutic use)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022